Molecular genetics and clinical applications for RH

Transfusion and Apheresis Science

Volumn 44, Issue 1, 2011, Pages 81-91

  Flegel, Willy A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood group; Molecular diagnostic; Molecular genetics; Rhesus; Transfusion

Indexed keywords

DNA; RECOMBINANT ANTIBODY; RHESUS ANTIBODY; RHESUS ANTIGEN; RHESUS C ANTIBODY; RHESUS D ANTIBODY; RHESUS D ANTIGEN; RHESUS E ANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; POLYPEPTIDE; RHCE PROTEIN; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD DONOR; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CELL FREE SYSTEM; DONOR SELECTION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENOTYPE; HAPLOTYPE; HUMAN; MATERNAL PLASMA; MOLECULAR GENETICS; MOLECULAR MODEL; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; PHENOTYPE; POPULATION RESEARCH; PREGNANCY; PRENATAL DIAGNOSIS; PROTEIN VARIANT; ZYGOSITY; ALLELE; AMINO ACID SUBSTITUTION; BLOOD TRANSFUSION REACTION; ERYTHROCYTE; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; NEWBORN HEMOLYTIC DISEASE; POPULATION GENETICS; RECIPIENT; RHESUS INCOMPATIBILITY;

ALLELES; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; CHROMOSOMES, HUMAN, PAIR 1; ERYTHROBLASTOSIS, FETAL; ETHNIC GROUPS; EVOLUTION, MOLECULAR; FEMALE; FETAL BLOOD; FORECASTING; GENE DUPLICATION; GENE FREQUENCY; GENOTYPE; HUMANS; MATERNAL-FETAL EXCHANGE; MODELS, MOLECULAR; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; PHENOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; PROTEIN CONFORMATION; RH-HR BLOOD-GROUP SYSTEM;

EID: 79951672550     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.12.013     Document Type: Article

References (114)

1. Denomme G.A., Flegel W.A. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008, 48(11):2461-2475.
2. Hillyer C.D., Shaz B.H., Winkler A.M., Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus. Med. Rev. 2008, 22(2):117-132.
3. Westhoff C.M. The potential of blood group genotyping for transfusion medicine practice. Immunohematology 2008, 24(4):190-195.
4. Avent N.D. Large-scale blood group genotyping: clinical implications. Br. J. Haematol. 2009, 144(1):3-13.
5. Huang C.H., Ye M. The Rh protein family: gene evolution, membrane biology, and disease association. Cell Mol. Life Sci. 2010, 67(8):1203-1218.
6. Cartron J.P., Colin Y. Structural and functional diversity of blood group antigens. Transfus. Clin. Biol. 2001, 8(3):163-199.
7. Tilley L., Green C., Poole J., Gaskell A., Ridgwell K., Burton N.M., et al. A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sang. 2010, 98(2):151-159.
8. Marini A.M., Matassi G., Raynal V., Andre B., Cartron J.P., Cherif-Zahar B. The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nat. Genet. 2000, 26(3):341-344.
9. Bruce L.J. Hereditary stomatocytosis and cation-leaky red cells - recent developments. Blood Cells Mol. Dis. 2009, 42(3):216-222.
10. Wagner F.F., Flegel W.A. RHCE represents the ancestral RH position, while RHD is the duplicated gene. Blood 2002, 99(6):2272-2273.
11. Wagner F.F., Flegel W.A. RHD gene deletion occurred in the Rhesus box. Blood 2000, 95(12):3662-3668.
12. Blancher A., Apoil P.A. Evolution of RH genes in hominoids: characterization of a gorilla RHCE-like gene. J. Hered. 2000, 91(3):205-210.
13. Flegr J., Novotna M., Lindova J., Havlicek J. Neurophysiological effect of the Rh factor. Protective role of the RhD molecule against Toxoplasma-induced impairment of reaction times in women. Neuro. Endocrinol. Lett. 2008, 29(4):475-481.
14. Hatfield J.S. The genetic basis of hair whorl, handedness, and other phenotypes. Med. Hypotheses 2006, 66(4):708-714.
15. Marini A.M., Urrestarazu A., Beauwens R., Andre B. The Rh (rhesus) blood group polypeptides are related to NH4+ transporters. Trends Biochem. Sci. 1997, 22(12):460-461.
16. Westhoff C.M., Ferreri-Jacobia M., Mak D.O., Foskett J.K. Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter. J. Biol. Chem. 2002, 277(15):12499-12502.
17. Burton N.M., Anstee D.J. Structure, function and significance of Rh proteins in red cells. Curr. Opin. Hematol. 2008, 15(6):625-630.
18. Cherif-Zahar B., Bloy C., Le Van Kim C., Blanchard D., Bailly P., Hermand P., et al. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc. Natl. Acad. Sci. USA 1990, 87(16):6243-6247.
19. Flegel W.A., von Zabern I., Doescher A., Wagner F.F., Strathmann K.P., Geisen C., et al. D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion 2009, 49(6):1059-1069.
20. Flegel W.A., von Zabern I., Doescher A., Wagner F.F., Vytiskova J., Pisacka M. DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. Transfusion 2008, 48(1):25-33.
21. Tippett P., Sanger R. Observations on subdivisions of the Rh antigen D. Vox Sang. 1962, 7:9-13.
22. Lomas C., Tippett P., Thompson K.M., Melamed M.D., Hughes-Jones N.C. Demonstration of seven epitopes on the Rh antigen D using human monoclonal anti-D antibodies and red cells from D categories. Vox Sang. 1989, 57(4):261-264.
23. Scott M. Rh serology - coordinator's report. Transfus. Clin. Biol. 1996, 3(6):333-337.
24. Daniels G.L. Human Blood Groups 2002, Blackwell Science, Oxford. 2 ed.
25. Reid M.E., Lomas-Francis C. The Blood Group Antigen Facts Book 2003, Academic Press, San Diego. 2 ed.
26. Lubenko A., Burslem S.J., Tandy J., Contreras M., Garner S.F., Wiener E. ISBT monoclonal antibody workshop: report on group 3 (anti-Rh) antibodies. Rev. Fr. Transfus. Immunohematol. 1988, 31(2):145-152.
27. Rouillac C., Colin Y., Hughes-Jones N.C., Beolet M., D'Ambrosio A.M., Cartron J.P., et al. Transcript analysis of D category phenotypes predicts hybrid Rh D-CE-D proteins associated with alteration of D epitopes. Blood 1995, 85(10):2937-2944.
28. Wagner F.F., Gassner C., Muller T.H., Schonitzer D., Schunter F., Flegel W.A. Molecular basis of weak D phenotypes. Blood 1999, 93(1):385-393.
29. Gane P., Le Van Kim C., Bony V., El Nemer W., Mouro I., Nicolas V., et al. Flow cytometric analysis of the association between blood group-related proteins and the detergent-insoluble material of K562 cells and erythroid precursors. Br. J. Haematol. 2001, 113(3):680-688.
30. Denomme G.A., Wagner F.F., Fernandes B.J., Li W., Flegel W.A. Partial D, weak D types, and novel RHD alleles among 33, 864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005, 45(10):1554-1560.
31. Gassner C., Doescher A., Drnovsek T.D., Rozman P., Eicher N.I., Legler T.J., et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion 2005, 45(4):527-538.
32. Kamesaki T., Kumada M., Omi T., Okuda H., Iwamoto S., Takahashi J., et al. A novel mutation in the RHD gene in Japanese individuals with weak D, encoding an amino acid change in the 11th transmembranous domain of the RhD protein [Letter]. Vox Sang. 2003, 84:141.
33. Kormoczi G.F., Forstemann E., Gabriel C., Mayr W.R., Schonitzer D., Gassner C. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types. Transfusion 2005, 45(10):1574-1580.
34. Lin I.L., Shih M.C., Hsieh M.H., Liu T.C., Chang S.E., Lin C.L., et al. Molecular basis of weak D in Taiwanese. Ann. Hematol. 2003, 82(10):617-620.
35. Muller T.H., Wagner F.F., Trockenbacher A., Eicher N.I., Flegel W.A., Schonitzer D., et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001, 41(1):45-52.
36. Shao C.P., Maas J.H., Su Y.Q., Kohler M., Legler T.J. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang. 2002, 83(2):156-161.
37. Ansart-Pirenne H., Asso-Bonnet M., Le Pennec P.-Y., Roussel M., Patereau C., Noizat-Pirenne F. RHD variants in whites: consequences for checking clinically relevant alleles. Transfusion 2004, 44(9):1282-1286.
38. Hemker M.B., Ligthart P.C., Berger L., van Rhenen D.J., van der Schoot C.E., Wijk P.A. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new rhce variant frequently found in African blacks. Blood 1999, 94(12):4337-4342.
39. Legler T.J., Maas J.H., Kohler M., Wagner T., Daniels G.L., Perco P., et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus. Med. 2001, 11(5):383-388.
40. Hasekura H., Ota M., Ito S., Hasegawa Y., Ichinose A., Fukushima H., et al. Flow cytometric studies of the D antigen of various Rh phenotypes with particular reference to Du and Del. Transfusion 1990, 30(3):236-238.
41. Wagner F.F., Frohmajer A., Flegel W.A. RHD positive haplotypes in D negative Europeans. BMC Genet. 2001, 2(1):10.
42. Luettringhaus T.A., Cho D., Ryang D.W., Flegel W.A. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion 2006, 46(12):2128-2137.
43. Kim J.Y., Kim S.Y., Kim C.A., Yon G.S., Park S.S. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion 2005, 45(3):345-352.
44. Kormoczi G.F., Gassner C., Shao C.P., Uchikawa M., Legler T.J. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005, 45(10):1561-1567.
45. Wagner T., Kormoczi G.F., Buchta C., Vadon M., Lanzer G., Mayr W.R., et al. Anti-D immunization by DEL red blood cells. Transfusion 2005, 45(4):520-526.
46. Flegel W.A., Gabriel C., Gassner W., Ruff H., Wagner F.F. RHD genotyping of blood donors may avoid anti-D immunization. Blood 2004, 104(11):739a.
47. Flegel W.A. Homing in on D antigen immunogenicity. Transfusion 2005, 45(4):466-468.
48. Yasuda H., Ohto H., Sakuma S., Ishikawa Y. Secondary anti-D immunization by DEL red blood cells. Transfusion 2005, 45(10):1581-1584.
49. Daniels G.L., Faas B.H., Green C.A., Smart E., Maaskant-van Wijk P.A., Avent N.D., et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998, 38(10):951-958.
50. Singleton B.K., Green C.A., Avent N.D., Martin P.G., Smart E., Daka A., et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D- negative blood group phenotype. Blood 2000, 95(1):12-18.
51. Shao C.P., Xiong W. A new hybrid RHD-positive, D antigen-negative allele. Transfus. Med. 2004, 14(2):185-186.
52. Flegel W.A. How I manage donors and patients with a weak D phenotype. Curr. Opin. Hematol. 2006, 13(6):476-483.
53. Shao C.P. Transfusion of RhD-positive blood in "Asia type" DEL recipients. N. Engl. J. Med. 2010, 362(5):472-473.
54. Carritt B., Blunt T., Avent N., Daniels G., Steers F. Rh null phenotypes are not due to a gross deletion and can occur on different Rh genetic backgrounds. Ann. Hum. Genet. 1993, 57(Pt 4):273-279.
55. Kato-Yamazaki M., Okuda H., Kawano M., Omi T., Iwamoto T., Ishimori T., et al. Molecular genetic analysis of the Japanese amorph rh(null) phenotype. Transfusion 2000, 40(5):617-618.
56. Huang C.H. The human Rh50 glycoprotein gene. Structural organization and associated splicing defect resulting in Rh(null) disease. J. Biol. Chem. 1998, 273(4):2207-2213.
57. Denomme G.A., Ryan G., Seaward P.G., Kelly E.N., Fernandes B.J. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17. Transfusion 2004, 44(9):1357-1360.
58. Chen Y.X., Peng J., Novaretti M., Reid M.E., Huang C.H. Deletion of arginine codon 229 in the Rhce gene alters e and f but not c antigen expression. Transfusion 2004, 44(3):391-398.
59. Flegel W.A., Wagner F.F., Chen Q., Schlanser G., Frame T., Westhoff C.M., et al. The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion 2006, 46(8):1334-1342.
60. Noizat-Pirenne F., Mouro I., Le Pennec P.Y., Ansart-Pirenne H., Juszczak G., Patereau C., et al. Two new alleles of the RHCE gene in Black individuals: the RHce allele ceMO and the RHcE allele cEMI. Br. J. Haematol. 2001, 113(3):672-679.
61. Noizat-Pirenne F., Lee K., Pennec P.Y., Simon P., Kazup P., Bachir D., et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002, 100(12):4223-4231.
62. Noizat-Pirenne F., Ansart-Pirenne H., Menanteau C., Braddock D., Rouzaud A.M., Klein M.T., et al. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs. Transfus. Clin. Biol. 2003, 10(5):319-323.
63. Noizat-Pirenne F., Tournamille C., Gallon P., Juszczak G., Rouger P., Ansart-Pirenne H. ceRA: an RH allele variant producing a new rare blood. Transfusion 2006, 46(7):1232-1236.
64. Scharberg E.A., Green C., Daniels G., Richter E., Kluter H., Bugert P. Molecular basis of the JAHK (RH53) antigen. Transfusion 2005, 45(8):1314-1318.
65. Strobel E., Noizat-Pirenne F., Hofmann S., Cartron J.P., Bauer M.F. The molecular basis of the Rhesus antigen Ew. Transfusion 2004, 44(3):407-409.
66. Tax M.G., van der Schoot C.E., van Doorn R., Douglas-Berger L., van Rhenen D.J., Maaskant-vanWijk P.A. RHC and RHc genotyping in different ethnic groups. Transfusion 2002, 42(5):634-644.
67. Tournamille C., Meunier-Costes N., Costes B., Martret J., Barrault A., Gauthier P., et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010, 50(1):13-19.
68. Westhoff C.M., Storry J.R., Walker P., Lomas-Francis C., Reid M.E. A new hybrid RHCE gene (CeNR) is responsible for expression of a novel antigen. Transfusion 2004, 44(7):1047-1051.
69. Wagner F.F., Ladewig B., Angert K.S., Heymann G.A., Eicher N.I., Flegel W.A. The DAU allele cluster of the RHD gene. Blood 2002, 100(1):306-311.
70. Wagner F.F., Ernst M., Sonneborn H.H., Flegel W.A. A D(V)-like phenotype is obliterated by A226P in the partial D DBS. Transfusion 2001, 41(8):1052-1058.
71. Flegel W.A. The Rhesus Immunization Surveillance 1998, DRK-Blutspendedienst Baden-Wurttemberg - Hessen, Ulm.
72. Cannon M., Pierce R., Taber E.B., Schucker J. Fatal hydrops fetalis caused by anti-D in a mother with partial D. Obstet. Gynecol. 2003, 102(5 Pt. 2):1143-1145.
73. Lurie S., Rotmensch S., Glezerman M. Prenatal management of women who have partial Rh (D) antigen. Br. J. Obstet. Gynaecol. 2001, 108(9):895-897.
74. Flegel W.A., Wagner F.F. Molecular genetics of RH. Vox Sang. 2000, 78(Suppl 2):109-115.
75. Bianchi D.W., Avent N.D., Costa J.M., van der Schoot C.E. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for prime(r) time. Obstet. Gynecol. 2005, 106(4):841-844.
76. Daniels G., Finning K., Martin P., Soothill P. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang. 2004, 87(4):225-232.
77. Faas B.H., Beuling E.A., Christiaens G.C., dem Borne A.E., van der Schoot C.E. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998, 352(9135):1196.
78. Lo Y.M.D., Hjelm N.M., Fidler C., Sargent I.L., Murphy M.F., Chamberlain P.F., et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N. Engl. J. Med. 1998, 339(24):1734-1738.
79. Chan K.C., Zhang J., Hui A.B., Wong N., Lau T.K., Leung T.N., et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 2004, 50(1):88-92.
80. Li Y., Zimmermann B., Rusterholz C., Kang A., Holzgreve W., Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin. Chem. 2004, 50(6):1002-1011.
81. Finning K., Martin P., Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann. NY Acad. Sci. 2004, 1022:119-123.
82. Finning K.M., Martin P.G., Soothill P.W., Avent N.D. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002, 42(8):1079-1085.
83. Legler T.J., Lynen R., Maas J.H., Pindur G., Kulenkampff D., Suren A., et al. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus. Apher. Sci. 2002, 27(3):217-223.
84. Rijnders R.J., Christiaens G.C., de Haas M., van der Schoot C.E. [Fetal DNA in maternal blood]. Ned. Tijdschr. Geneeskd. 2004, 148(4):170-174.
85. Rouillac-Le Sciellour C., Puillandre P., Gillot R., Baulard C., Metral S., Le Van K.C., et al. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol. Diagn. 2004, 8(1):23-31.
86. Engelfriet C.P., Reesink H.W., Judd W.J., Ulander V.M., Kuosmanen M., Koskinen S., et al. Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang. 2003, 85(4):328-337.
87. Westhoff C.M. The Rh blood group system in review: a new face for the next decade. Transfusion 2004, 44(11):1663-1673.
88. Flegel W.A., Denomme G.A., Yazer M.H. On the complexity of D antigen typing: a handy decision tree in the age of molecular blood group diagnostics. J. Obstet. Gynaecol. Can. 2007, 29(9):746-752.
89. Nielsen L.K., Green T.H., Sandlie I., Michaelsen T.E., Dziegiel M.H. In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn. Transfusion 2008, 48(1):12-19.
90. Kjaersgaard M., Aslam R., Kim M., Speck E.R., Freedman J., Stewart D.I., et al. Epitope specificity and isotype of monoclonal anti-D antibodies dictate their ability to inhibit phagocytosis of opsonized platelets. Blood 2007, 110(4):1359-1361.
91. Chiu R.W., Murphy M.F., Fidler C., Zee B.C., Wainscoat J.S., Lo Y.M. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin. Chem. 2001, 47(4):667-672.
92. Li Y., Zimmermann B., Zhong X.Y., Gupta A.K., Holzgreve W., Hahn S. Determination of RHD zygosity using real-time quantitative PCR. Swiss. Med. Wkly. 2003, 133(31-32):442-445.
93. Yu X., Wagner F.F., Witter B., Flegel W.A. Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion 2006, 46(8):1343-1351.
94. Blunt T., Steers F., Daniels G., Carritt B. Lack of RH C/E expression in the Rhesus D-phenotype is the result of a gene deletion. Ann. Hum. Genet. 1994, 58(Pt. 1):19-24.
95. Wagner F.F., Kasulke D., Kerowgan M., Flegel W.A. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany. Infusionsther. Transfusionsmed. 1995, 22(5):285-290.
96. Flegel W.A., Wagner F.F. Molecular biology of partial D and weak D: implications for blood bank practice. Clin. Lab. 2002, 48(1+2):53-58.
97. Wagner F.F., Eicher N.I., Jorgensen J.R., Lonicer C.B., Flegel W.A. DNB: a partial D with anti-D frequent in Central Europe. Blood 2002, 100(6):2253-2256.
98. Garratty G. Do we need to be more concerned about weak D antigens?. Transfusion 2005, 45(10):1547-1551.
99. Wagner F.F., Frohmajer A., Ladewig B., Eicher N.I., Lonicer C.B., Muller T.H., et al. Weak D alleles express distinct phenotypes. Blood 2000, 95(8):2699-2708.
100. Legler T.J., Eber S.W., Lakomek M., Lynen R., Maas J.H., Pekrun A., et al. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion 1999, 39(8):852-855.
101. Reid M.E., Rios M., Powell V.I., Charles-Pierre D., Malavade V. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2000, 40(1):48-53.
102. Rios M., Hue-Roye K., Storry J.R., Reiss R.F. Cell typing the sensitized transfusion-dependent patient. Ann. Clin. Lab Sci. 2000, 30(4):379-386.
103. Flegel W.A., Khull S., Wagner F.F. Primary anti-D immunization by weak D type 2 RBC. Transfusion 2000, 40(4):428-434.
104. Anstee D.J. Goodbye to agglutination and all that?. Transfusion 2005, 45(5):652-653.
105. Avent N.D. High variability of the RH locus in different ethnic backgrounds. Transfusion 2005, 45(3):293-294.
106. Beiboer S.H., Wieringa-Jelsma T., Maaskant-van Wijk P.A., van der Schoot C.E., van Zwieten R., Roos D., et al. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005, 45(5):667-679.
107. Denomme G.A., Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005, 45(5):660-666.
108. Hashmi G., Shariff T., Seul M., Vissavajjhala P., Hue-Roye K., Charles-Pierre D., et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005, 45(5):680-688.
109. Flegel WA. BloodGen consortium members. The future of blood grouping: mass genotyping for blood groups and beyond. Mannheim: DRK-Blutspendedienst Baden-Wurttemberg - Hessen; 2004. http://www.uni-ulm.de/~wflegel/RH/SympDGTI2004.
110. Flegel W.A., Wagner F.F., Muller T.H., Gassner C. Rh phenotype prediction by DNA typing and its application to practice. Transfus. Med. 1998, 8(4):281-302.
111. Reid M.E. DNA analysis to find rare blood donors when antisera is not available. Vox Sang. 2002, 83(Suppl. 1):91-93.
112. Reid M.E., Lomas-Francis C. Molecular approaches to blood group identification. Curr. Opin. Hematol. 2002, 9(2):152-159.
113. Reid M.E. Molecular biology in transfusion medicine: current applications and future practice. Curr. Hematol. Rep. 2002, 1(2):134-141.
114. Reid M.E. Applications of DNA-based assays in blood group antigen and antibody identification. Transfusion 2003, 43(12):1748-1757.